Neogenomics NEO
NASDAQ NEO
$19.14 -0.27 (-1.42%)
As of: Sep 22, 2026 · 10:53 AM EDT

Neogenomics (NEO) Asset Writedowns and Impairment (2010 - 2025)

Neogenomics' (NEO) quarterly Asset Writedowns and Impairment came in at $673000.0 in Q4 2025, up 302.99% on a YoY basis from $167000.0 in Q4 2024, and down 90.5% quarter-over-quarter from $7.1 million in Q3 2025.

Analysis

Neogenomics (NEO) Asset Writedowns and Impairment (2010 - 2025) Analysis & Trends

Neogenomics (NEO) has reported Asset Writedowns and Impairment for 12 consecutive years, with $673000.0 the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Asset Writedowns and Impairment rose 302.99% year-over-year to $673000.0; the trailing twelve-month figure through Jun 2026 stood at $27.8 million (up 37.57% YoY), and the FY2025 full-year result was $27.8 million, up 5460.0% from the prior year.
  • Asset Writedowns and Impairment fell to $673000.0 in Q4 2025 per NEO's latest filing, from $7.1 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $20.0 million in Q2 2025 and bottomed at $43000.0 in Q3 2023.
  • Historically, Asset Writedowns and Impairment has averaged $3.4 million across 4 years, with a median of $718000.0 in 2022.
  • The sharpest annual moves came in 2024 and 2025: Asset Writedowns and Impairment sank 84.29% in 2024, then surged 302.99% in 2025.
  • Over 4 years, Asset Writedowns and Impairment stood at $718000.0 in 2022, then slumped by 94.01% to $43000.0 in 2023, then surged by 288.37% to $167000.0 in 2024, then soared by 302.99% to $673000.0 in 2025.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $673000.0, $7.1 million, and $20.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn
10 Neogenomics 2.55 Bn 2.40 Bn 91.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 673,000.00
Sep 30, 2025 7.09 Mn
Jun 30, 2025 20.04 Mn
Dec 31, 2024 167,000.00
Mar 31, 2024 145,000.00
Sep 30, 2023 43,000.00
Jun 30, 2023 737,000.00
Mar 31, 2023 923,000.00
Dec 31, 2022 718,000.00
Dec 31, 2017 5.62 Mn
Sep 30, 2017 5.00 Mn
Jun 30, 2017 4.24 Mn
Mar 31, 2017 3.78 Mn
Dec 31, 2016 3.67 Mn
Sep 30, 2016 2.75 Mn
Jun 30, 2016 2.77 Mn
Mar 31, 2016 2.66 Mn
Dec 31, 2015 469,000.00
Sep 30, 2015 546,000.00
Jun 30, 2015 701,000.00
API Access

Neogenomics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=NEO&period=max&api_key=YOUR_API_KEY